Mixing Test in a Case of Combined Acquired Hemophilia A and Coagulation Factor Deficiency: A Case Report

Acquired hemophilia A and B are rare autoimmune disorders where antibodies inhibit coagulation factors VIII and IX, leading to excessive bleeding. Acquired hemophilia displays an <i>inhibitor pattern</i> in mixing tests. Meanwhile, coagulation factor deficiency, often due to liver disease, results from reduced synthesis of coagulation factors and shows a <i>deficiency pattern</i> in mixing tests. However, overlapping features can complicate differentiation. A <i>percent correction </i>method in the mixing test improved accuracy in distinguishing between the <i>inhibitor pattern</i> and the <i>deficiency pattern</i>. Using this method, a complex case involving both acquired hemophilia A and liver-related coagulation factor deficiency was successfully diagnosed. A 70-year-old man presented with subcutaneous, intracranial bleeding, and gastrointestinal hemorrhage. The laboratory data revealed severe anemia (hemoglobin 5.7 g/dL) without thrombocytopenia. Coagulation studies showed significantly prolonged activated partial thromboplastin time (APTT >100 seconds), mildly prolonged prothrombin time (PT 13.0 seconds), and a low fibrinogen (144 mg/dL). Given the disproportionately prolonged APTT, we performed a 1:1 <i>percent correction</i> of the mixing test, which revealed a <i>deficiency pattern</i> before treatment. We administered fresh frozen plasma (FFP); however, the coagulopathy was not improved. After the FFP treatment, the mixing test revealed a <i>deficiency pattern</i> in the early phase and an <i>inhibitor pattern</i> in the late phase. The coagulation factors were nonspecifically decreased. The inhibitor for coagulation factor VIII was identified. We diagnosed the patient with acquired hemophilia. Diagnosing coagulopathy is especially challenging when a patient has both acquired hemophilia and coagulation factor deficiency, as mixing test patterns may overlap and lose distinct characteristics. The 1:1 <i>percent correction</i> method proved to be the most reliable approach for distinguishing between deficiency and inhibitor-related patterns. In this case, acquired hemophilia A was the primary cause of severe bleeding with underlying coagulation factor deficiency. Combining mixing tests with plasma supplementation helped clarify the dual pathogenesis.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-11-20
DOI
https://doi.org/10.7759/cureus.97307
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mixing Test in a Case of Combined Acquired Hemophilia A and Coagulation Factor Deficiency: A Case Report

Osamu Imataki, Kei Takahata, Yuko Mukai, Masayo Tamura et al.
Cureus
Hemophilia Treatment and Research
article

Mixing Test in a Case of Combined Acquired Hemophilia A and Coagulation Factor Deficiency: A Case Report

Osamu Imataki, Kei Takahata, Yuko Mukai, Masayo Tamura, Akira Kitanaka
article en

Abstract

Acquired hemophilia A and B are rare autoimmune disorders where antibodies inhibit coagulation factors VIII and IX, leading to excessive bleeding. Acquired hemophilia displays an <i>inhibitor pattern</i> in mixing tests. Meanwhile, coagulation factor deficiency, often due to liver disease, results from reduced synthesis of coagulation factors and shows a <i>deficiency pattern</i> in mixing tests. However, overlapping features can complicate differentiation. A <i>percent correction </i>method in the mixing test improved accuracy in distinguishing between the <i>inhibitor pattern</i> and the <i>deficiency pattern</i>. Using this method, a complex case involving both acquired hemophilia A and liver-related coagulation factor deficiency was successfully diagnosed. A 70-year-old man presented with subcutaneous, intracranial bleeding, and gastrointestinal hemorrhage. The laboratory data revealed severe anemia (hemoglobin 5.7 g/dL) without thrombocytopenia. Coagulation studies showed significantly prolonged activated partial thromboplastin time (APTT >100 seconds), mildly prolonged prothrombin time (PT 13.0 seconds), and a low fibrinogen (144 mg/dL). Given the disproportionately prolonged APTT, we performed a 1:1 <i>percent correction</i> of the mixing test, which revealed a <i>deficiency pattern</i> before treatment. We administered fresh frozen plasma (FFP); however, the coagulopathy was not improved. After the FFP treatment, the mixing test revealed a <i>deficiency pattern</i> in the early phase and an <i>inhibitor pattern</i> in the late phase. The coagulation factors were nonspecifically decreased. The inhibitor for coagulation factor VIII was identified. We diagnosed the patient with acquired hemophilia. Diagnosing coagulopathy is especially challenging when a patient has both acquired hemophilia and coagulation factor deficiency, as mixing test patterns may overlap and lose distinct characteristics. The 1:1 <i>percent correction</i> method proved to be the most reliable approach for distinguishing between deficiency and inhibitor-related patterns. In this case, acquired hemophilia A was the primary cause of severe bleeding with underlying coagulation factor deficiency. Combining mixing tests with plasma supplementation helped clarify the dual pathogenesis.

CureusVol. 17(11)
Kawasaki Medical School (JP)
Openalex Percentile: Top 54%
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.